Methods for inhibiting angiogenesis using EGFL8 antagonists

Details for Australian Patent Application No. 2009205428 (hide)

Owner GENENTECH, INC.

Inventors Lu, Han; Ye, Weilan

Agent Griffith Hack

Pub. Number AU-A-2009205428

PCT Pub. Number WO2009/091810

Priority 61/020,960 14.01.08 US

Filing date 14 January 2009

Wipo publication date 23 July 2009

International Classifications

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 27/00 (2006.01) Drugs for disorders of the senses

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

12 August 2010 PCT application entered the National Phase

  PCT publication WO2009/091810 Priority application(s): WO2009/091810

19 August 2010 Amendment Made

  The nature of the amendment is: Amend the invention title to read Inhibiting angiogenesis using EGFL8 antagonists

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009205429-Apparatus and methods for fracture repair

2009205426-Personal network access control system and method